Winston Medical Supply Co., Ltd. (TPEX:6817)

Taiwan · Delayed Price · Currency is TWD

38.85

+0.80 (2.10%)

Nov 10, 2026, 1:10 PM CST

Market Cap	715.50M -64.2%
Revenue (ttm)	632.80M -12.6%
Net Income	82.47M -38.6%
EPS	4.47 -38.4%
Shares Out	18.42M
PE Ratio	8.69
Forward PE	n/a
Dividend	5.00 (12.87%)
Ex-Dividend Date	Jun 16, 2026

Volume	2,260
Open	38.00
Previous Close	38.05
Day's Range	37.15 - 38.90
52-Week Range	37.05 - 111.00
Beta	0.22
Analysts	n/a
Price Target	n/a
Est. Earnings	Nov 13, 2026

About Winston Medical Supply

Winston Medical Supply Co., Ltd. develops, manufactures, and distributes pharmaceuticals, nutrition supplements, and cosmeceutical products in Taiwan and internationally. The company offers sterile ophthalmic preparations comprising gels, suspensions, solutions, and emulsions; hormone preparations, which primarily cover birth control and oral suspension for cancer related cachexia; external use preparations comprising ointments; and other oral preparations that are in oral dosage forms, such as powders, troches, tablets, film coated tablets, ch... [Read more]

Industry Drug Manufacturers - Specialty & Generic

Sector Healthcare

Founded 1974

Employees 180

Stock Exchange Taipei Exchange

Ticker Symbol 6817

Full Company Profile

Financial Performance

In 2025, Winston Medical Supply's revenue was 700.07 million, an increase of 0.72% compared to the previous year's 695.08 million. Earnings were 117.29 million, a decrease of -10.87%.

Financial Statements